Addus HomeCare Corporation (ADUS) vs SELLAS Life Sciences Group, Inc. (SLS)

A side-by-side comparison of Addus HomeCare Corporation and SELLAS Life Sciences Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADUS vs SLS

growth of $100 · dividends reinvested · last 10y
ADUS +333.9% (+15.8%/yr)SLS -99.9% (-48.7%/yr)ADUS compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$434$0
ADUS SLS

ADUS vs SLS: by the numbers

  • •ADUS is the larger company ($2.11B vs $2.11B market cap).
  • •ADUS is profitable (7.13% net margin) while SLS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricADUSSLS
P/E ratio19.85N/A
Forward P/E16.06N/A
PEG ratio0.98N/A
P/S ratio1.43N/A
P/B ratio1.8415.33
EV / EBITDA12.86N/A
FCF yield7.25%N/A

Profitability

MetricADUSSLS
Gross margin32.36%0.00%
Operating margin10.04%0.00%
Net margin7.13%0.00%
ROE9.17%-23.58%
ROIC8.61%-25.45%

Growth (annualized)

MetricADUSSLS
Revenue CAGR (5Y)12.67%N/A
EPS CAGR (5Y)19.61%N/A
FCF CAGR (5Y)24.41%N/A
Total return CAGR (5Y)8.33%6.20%

Frequently asked

Is ADUS or SLS more profitable?
ADUS runs the higher net margin — ADUS at 7.13% versus SLS at 0.00%.
How have ADUS and SLS total returns compared?
Over the past 10 years, ADUS delivered 15.62% and SLS delivered -49.07% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.